Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats.

Biodistribution of gold nanoparticles (AuNPs) in more than 25 organs were examined on 1 day, 1 week, 1 month and 2 months after a single intravenous (i.v.) injection in rats. Au was rapidly and consistently accumulated in liver (49.4+/-50.4-72.2+/-40.5 ng/g) and spleen (8.4+/-5.0-9.5+/-6.4 ng/g) throughout the entire timeframe of the study (2 months). Significant accumulation of Au in kidney (up to 5.5+/-2.5 ng/g) and testis (up to 0.6+/-0.1 ng/g) occurred from 1 month post-injection when Au level in urine and feces decreased. Significant increase of Au in blood occurred 2 months after injection, coincident with the delayed accumulation in kidney. Au accumulation in lungs was found at 1 day post-injection but decreased within a week. No accumulation of Au was found in the brain. Microarray results of liver and spleen point to significant effects on genes related to detoxification, lipid metabolism, cell cycle, defense response, and circadian rhythm. These results demonstrate that significant biodistribution of Au occurs in the body over 2 months after a single i.v. injection of AuNPs, accompanied by gene expression changes in target organs.

[1]  M. Botelho,et al.  Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles , 2002, Journal of drug targeting.

[2]  Christine Pohl,et al.  Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441 , 2009, Particle and Fibre Toxicology.

[3]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[4]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Gan-Moog Chow,et al.  In vivo toxic studies and biodistribution of near infrared sensitive Au–Au2S nanoparticles as potential drug delivery carriers , 2008, Journal of materials science. Materials in medicine.

[6]  Choon Nam Ong,et al.  Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts In Vitro , 2008 .

[7]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[8]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[9]  Chunxin Zhang,et al.  Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[10]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[11]  S. Mahdihassan.  Cinnabar-gold as the best alchemical drug of longevity, called Makaradhwaja in India. , 1985, The American journal of Chinese medicine.

[12]  Chao-Liang Wu,et al.  Amelioration of collagen-induced arthritis in rats by nanogold. , 2007, Arthritis and rheumatism.

[13]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[14]  Ming-Hsien Tsai,et al.  Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment , 2007, Environmental health perspectives.

[15]  Viroj Wiwanitkit,et al.  Effect of gold nanoparticles on spermatozoa: the first world report. , 2009, Fertility and sterility.

[16]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[17]  Tonghua Wang,et al.  Translocation and fate of multi-walled carbon nanotubes in vivo , 2007 .

[18]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[19]  D. Leslie-Pelecky,et al.  Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. , 2008, Molecular pharmaceutics.

[20]  B. H. Miller,et al.  Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock , 2002, Cell.

[21]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[22]  Valery V Tuchin,et al.  Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery , 2009, Journal of biophotonics.

[23]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[24]  M. Garnett,et al.  Nanomedicines and nanotoxicology: some physiological principles. , 2006, Occupational medicine.

[25]  W. Kreyling,et al.  Translocation of Inhaled Ultrafine Particles to the Brain , 2004, Inhalation toxicology.

[26]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[27]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[28]  Horst A von Recum,et al.  Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. , 2006, Macromolecular bioscience.

[29]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[30]  Christopher L. Brown,et al.  Nanogold-pharmaceutics (i) the use of colloidal gold to treat experimentally-induced arthritis in rat models; (ii) characterization of the gold in Swarna bhasma, a microparticulate used in traditional Indian medicine , 2007 .

[31]  D E Griswold,et al.  Biologic actions and pharmacokinetic studies of auranofin. , 1983, The American journal of medicine.

[32]  W. Brandau,et al.  Cellular uptake and toxicity of Au55 clusters. , 2005, Small.

[33]  G. E. Duffield,et al.  DNA Microarray Analyses of Circadian Timing: The Genomic Basis of Biological Time , 2003, Journal of neuroendocrinology.

[34]  A. Almeida,et al.  Lymphatic uptake of lipid nanoparticles following endotracheal administration , 2006, Journal of microencapsulation.

[35]  D. Richards,et al.  GOLD AND ITS RELATIONSHIP TO NEUROLOGICAL/GLANDULAR CONDITIONS , 2002, The International journal of neuroscience.

[36]  Lawrence Tamarkin,et al.  Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery , 2004, Drug delivery.

[37]  Håkan Wallin,et al.  Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[38]  R. Allada,et al.  Biological clocks , 2000 .

[39]  W. Buchanan,et al.  The history of gold therapy in rheumatoid disease. , 1985, Seminars in arthritis and rheumatism.

[40]  M Geso,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.

[41]  J. Finkelstein,et al.  Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System , 2006, Environmental health perspectives.

[42]  Håkan Wallin,et al.  Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.

[43]  R. Akhtar,et al.  Circadian Cycling of the Mouse Liver Transcriptome, as Revealed by cDNA Microarray, Is Driven by the Suprachiasmatic Nucleus , 2002, Current Biology.

[44]  C. Ong,et al.  Translocation and effects of gold nanoparticles after inhalation exposure in rats , 2007 .